Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk ASfiledCriticalNovo Nordisk AS
Priority claimed from EP89908155Aexternal-prioritypatent/EP0480923B1/de
Publication of DE68909617D1publicationCriticalpatent/DE68909617D1/de
Application grantedgrantedCritical
Publication of DE68909617T2publicationCriticalpatent/DE68909617T2/de
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
C07K14/745—Blood coagulation or fibrinolysis factors
C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
DE89908155T1989-07-041989-07-04Verfahren zur herstellung von proteinen mit fviii aktivität und/oder fviii derivate.
Expired - LifetimeDE68909617T2
(de)